Delivery Order SPE2DR25D3005-SPE2DR26FP8JB
- Not listed
- The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of LENVIMA 14 mg daily dose tablets in a 60-count package. The contract is a firm fixed price delivery order with an ultimate completion date of January 21, 2026, and represents a non-competitive, competitively awarded transaction. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of LENVIMA 8 mg daily dose tablets (60-count units) under a firm fixed-price contract valued at $21,547.44. This competitively awarded, non-set-aside delivery order has an ultimate completion date of November 26, 2025, and is being fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen...
- The Defense Logistics Agency awarded a $10,773.72 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of LENVIMA 8 mg daily dose tablets in quantities of 60 units. The contract is scheduled for completion by December 31, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $30,669.75 firm fixed price delivery order to AmerisourceBergen Drug Corp for LENVIMA 20 mg daily dose tablets (60-count supply), with an ultimate completion date of August 29, 2025. This non-set-aside competitive award leverages AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle running through December 2026 that enables the company to furnish...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose (60-count supply) valued at $10,773.72 on November 24, 2025, with completion expected by December 16, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded through open competition. The performance location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. LENVIMA (lenvatinib) is a targeted cancer therapy...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $21,547.44 to AmerisourceBergen Drug Corp for the supply of LENVIMA 10 mg daily dose (30-count package) on December 8, 2025. This firm fixed-price contract, with an ultimate completion date of December 30, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $9,910.95 firm fixed-price delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 MG daily dose (60-count supply) on June 18, 2025, with completion targeted for July 11, 2025. This non-set-aside contract represents a direct pharmaceutical supply delivery to support federal medical procurement needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of LENVIMA 10 MG daily dose (30-count packages) valued at $10,773.72. This is a firm fixed price delivery order with no set-aside designation, issued under competitive procedures and scheduled for completion by January 14, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a delivery order valued at $32,321.16 to AmerisourceBergen Drug Corp for the supply of LENVIMA (lenvatinib) 14 mg daily dose in quantities of 60 tablets. This is a firm fixed-price, competitive delivery order with no set-aside designation, issued on December 3, 2025, with an ultimate completion date of December 24, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,910.95 to AmerisourceBergen Drug Corp for the supply of LENVIMA 18 mg daily dose in a 90-day supply. The contract, executed on April 24, 2025, with completion targeted for May 15, 2025, utilizes a firm fixed price structure with no set-aside designation, indicating competitive award. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- SPE2DR25D3005Indefinite Delivery Contract
- SPE2DR25D3005-SPE2DR26FP8JBDelivery Order
The Defense Logistics Agency awarded a $10,773.72 delivery order to AmerisourceBergen Drug Corp for LENVIMA 14 mg daily dose tablets (60-count supply) on January 5, 2026, with completion targeted for January 27, 2026. This firm fixed-price contract represents a non-set-aside competitive award to the pharmaceutical distributor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, regularly supplies brand-name and generic medications, vaccines, and specialized medical supplies to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. LENVIMA, a specialty oncology medication, aligns with the company's demonstrated portfolio of delivering prescription pharmaceuticals across multiple therapeutic domains. The IDC framework allows AmerisourceBergen to fulfill federal medical supply requirements flexibly, with the Defense Logistics Agency currently planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts potentially involving multiple regional awards among separate contractors.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.8k | 1/4/26 |